NeuralMed

Founded in 2018 in Sao Paulo, Brazil, NeuralMed develops advanced healthcare technology, focusing primarily on optimizing patient triage.NeuralMed offers advanced artificial intelligence-driven solutions designed to optimize patient triage and enhance healthcare delivery. Their core product, the Atlas Finder, enables healthcare providers to identify high-risk patients—specifically those with suspicious pulmonary and breast nodules—by analyzing medical reports and examination results. The technology unifies and processes data from various sources, creating predictive models that facilitate timely interventions, ultimately improving patient outcomes. NeuralMed's offerings cater to a broad client base including over 200 hospitals and healthcare systems, primarily across Brazil, with aspirations for expansion into other Latin American markets.NeuralMed's revenue is generated through partnerships and subscriptions with healthcare providers, leveraging a business-to-business (B2B) model. Clients typically engage NeuralMed by subscribing to its software solutions, which include the Atlas Finder and the Atlas Tracker, both designed to support patient identification and care management. The revenue structure is based on service agreements that may include initial setup fees and recurring subscription costs for continued access to the software, support services, and ongoing updates. Additionally, NeuralMed aims to expand its market reach into other Latin American countries, leveraging the recent investment to support this growth strategy.

1. Series A

   Nov 16, 2022

   Amount

   $1.9M

   Investors

   Locked